Suppressive effects of the sodium-glucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice

Kato, J; Shirakami, Y; Ohnishi, M; Mizutani, T; Kubota, M; Sakai, H; Ibuka, T; Tanaka, T; Shimizu, M

Shirakami, Y (reprint author), Gifu Univ, Grad Sch Med, Dept Gastroenterol, 1-1 Yanagido, Gifu 5011194, Japan.

ONCOLOGY REPORTS, 2019; 42 (6): 2797

Abstract

Sodium-glucose cotransporter 2 inhibitors were developed for the treatment of diabetes mellitus. Although recent studies have indicated that sodium-gl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索